TY - JOUR
T1 - Intestinal occlusion by gynecological cancers treated by percutaneous endoscopic gastrostomy and lanreotide
T2 - an Aviano National Cancer Institute experience
AU - Budel, Martina
AU - Martella, Luca
AU - Zambon, Laura
AU - Morson, Isabella
AU - Giorda, Giorgio
AU - Cannizzaro, Renato
N1 - Funding Information:
The project was supported by the Italian Ministry of Health (Ricerca Corrente) [no grant number provided].
Publisher Copyright:
© 2020, The Author(s).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2021/2
Y1 - 2021/2
N2 - The Commentary reports on our experience in Centro di Riferimento Oncologico IRCCS Aviano about the integrated and combined treatment with percutaneous endoscopic gastrostomy and lanreotide in patients with bowel obstructions by ovarian cancer and peritoneal carcinomatosis. We treated patients with gynecological cancers and bowel obstruction with percutaneous endoscopic gastrostomy and, when patients were partially responsive, with lanreotide. We registered a constant overall benefit for the quality of life and for the control of symptoms, which is very important especially during the home care follow-up of terminal patients.
AB - The Commentary reports on our experience in Centro di Riferimento Oncologico IRCCS Aviano about the integrated and combined treatment with percutaneous endoscopic gastrostomy and lanreotide in patients with bowel obstructions by ovarian cancer and peritoneal carcinomatosis. We treated patients with gynecological cancers and bowel obstruction with percutaneous endoscopic gastrostomy and, when patients were partially responsive, with lanreotide. We registered a constant overall benefit for the quality of life and for the control of symptoms, which is very important especially during the home care follow-up of terminal patients.
KW - Gynecological cancers
KW - Lanreotide
KW - Percutaneous endoscopic gastrostomy
UR - http://www.scopus.com/inward/record.url?scp=85090772839&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090772839&partnerID=8YFLogxK
U2 - 10.1007/s00520-020-05745-x
DO - 10.1007/s00520-020-05745-x
M3 - Comment/debate
C2 - 32914327
AN - SCOPUS:85090772839
VL - 29
SP - 547
EP - 549
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
SN - 0941-4355
IS - 2
ER -